Compound details
Obtusilactone A
| Compound ID | CDAMM01688 |
|---|---|
| Common name | Obtusilactone A | IUPAC name | 4-hydroxy-5-methylidene-3-tetradecylideneoxolan-2-one |
| Molecular formula | C19H32O3 |
| Retention time | 19.38 |
|---|---|
| Adduct | [2M+Na]+ |
| Actual mz | 639.466 | Theoretical mz | 639.459 |
| Error | 10.92 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.0429 |
| Inchi key | FCLYKYQBTSMTJB-ICFOKQHNNA-N |
|---|---|
| Smiles | O=C1OC(=C)C(O)C1=CCCCCCCCCCCCCC |
| Superclass | Organoheterocyclic compounds |
| Class | Oxolanes |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P17612 | PRKACA | cAMP-dependent protein kinase alpha-catalytic subunit | T12808 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| P06746 | POLB | DNA polymerase beta (by homology) | T06958 | SEA |
| Q02156 | PRKCE | Protein kinase C epsilon | T00895 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| P30307 | CDC25C | Dual specificity phosphatase Cdc25C | T40569 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T12808 | DI0279 | Muscular atrophy | [ICD-11: 8B61] | P17612 | PRKACA |
| T06958 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P06746 | POLB |
| T00895 | DI0033 | Anxiety disorder | [ICD-11: 6B00-6B0Z] | Q02156 | PRKCE |
| T00895 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q02156 | PRKCE |